These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11003364)

  • 21. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
    Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
    Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver transplantation in a child with liver cirrhosis caused by langerhans cell histiocytosis: a case report.
    Wang Q; Jin S; Xiang B; Chen J
    BMC Pediatr; 2022 Jan; 22(1):18. PubMed ID: 34980070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
    Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
    Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
    Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
    Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
    Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sclerosing cholangitis revealing Langerhans cell histiocytosis in a 15-month-old child].
    Sabib M; Ettair S; Erreimi N; Mouane N
    Arch Pediatr; 2011 Sep; 18(9):974-8. PubMed ID: 21816590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.
    Brandsaeter B; Schrumpf E; Bentdal O; Brabrand K; Smith HJ; Abildgaard A; Clausen OP; Bjoro K
    Liver Transpl; 2005 Nov; 11(11):1361-9. PubMed ID: 16184522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment results of Langerhans cell histiocytosis with LSH II protocol].
    Mottl H; Ganevová M; Radvanská J; Chánová M; Smelhaus V; Kodet R; Mrhalová M; Tichý M
    Cas Lek Cesk; 2005; 144(11):753-5. PubMed ID: 16335702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Langerhans' cell histiocytosis of the liver. Differential diagnosis of a rare chronic destructive sclerosing cholangitis].
    Haas S; Theuerkauf I; Kühnen A; Wickesberg A; Fischer HP
    Pathologe; 2003 Mar; 24(2):119-23. PubMed ID: 12673501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Langerhans' cell granuloma confined to the bile duct.
    Finn LS; Jaffe R
    Pediatr Pathol Lab Med; 1997; 17(3):461-8. PubMed ID: 9185224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence of primary sclerosing cholangitis after liver transplantation.
    Graziadei IW
    Liver Transpl; 2002 Jul; 8(7):575-81. PubMed ID: 12089708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric Langerhans cell histiocytosis of the lateral skull base.
    Majumder A; Wick CC; Collins R; Booth TN; Isaacson B; Kutz JW
    Int J Pediatr Otorhinolaryngol; 2017 Aug; 99():135-140. PubMed ID: 28688556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesteatoma secondary to temporal bone involvement by Langerhans cell histiocytosis: a complication amenable to curative surgery.
    Roger G; Dupré M; Leboulanger N; Godey B; Thomas C; Gandemer V; Bordure P; Garabedian EN; Donadieu J
    Otol Neurotol; 2009 Feb; 30(2):190-3. PubMed ID: 19169133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late-onset graft-versus-host disease after pediatric living-related liver transplantation for Langerhans cell histiocytosis.
    Yuksekkaya HA; Arikan C; Tumgor G; Aksoylar S; Kilic M; Aydogdu S
    Pediatr Transplant; 2011 Sep; 15(6):E105-9. PubMed ID: 21884342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of children younger than 24 months with langerhans cell histiocytosis and bone involvement: a report from a single institution.
    Kamath S; Arkader A; Jubran RF
    J Pediatr Orthop; 2014 Dec; 34(8):825-30. PubMed ID: 25387157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of adult multisystemic Langerhans cell histiocytosis with psoralen-UV-A, prednisolone, mercaptopurine, and vinblastine.
    von Stebut E; Schadmand-Fischer S; Bräuninger W; Kreft A; Doberauer C; Steinbrink K
    Arch Dermatol; 2008 May; 144(5):649-53. PubMed ID: 18490592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs. late presentation.
    Buis CI; Verdonk RC; Van der Jagt EJ; van der Hilst CS; Slooff MJ; Haagsma EB; Porte RJ
    Liver Transpl; 2007 May; 13(5):708-18. PubMed ID: 17457932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late outcomes in children with Langerhans cell histiocytosis.
    Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
    Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.